|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endoglin(CD105):a powerful therapeutic target on tumor-associated angiogenetic blood vessels显示文摘 | Fonsatti E Altomonte M Nicotra MR | 2003 | Oncogene2003，22，： | 1 |
| 2 | Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments显示文摘 | Baldi G Altomonte F Altomonte M | 2006 | Cerebrovasc Dis2006，22，4： | 1 |
| 3 | Endoglin (CD105): a powerful therapeutictarget on tumor-associated angiogenie blood vessels显示文摘 | Fonsatti E Altomonte M Nicotra M R | 2003 | Oncogene2003，22，： | 1 |
| 4 | Endoglin:an accessory component of the TGFβ-binding receptor complex with diagnostic,prognostic,and bioimmunotherapeutic potential in human malignancies显示文摘 | Fonsatti E Del Vecchio L Altomonte M | 2001 | J Cell Physiol2001，188，： | 1 |
| 5 | Endoglin: An accessory component of the TGF-b-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies 显示文摘 | Fonsatti E Del Vecchio L Altomonte M | 2001 | J Cell Physio12001，188，1： | 1 |
| 6 | Targeting cancer vasculature via endoglin/CD105:a novel antibody-based diagnostic and therapeutic strategy in solid tumours显示文摘 | Fonsatti E Nicolay H J Altomonte M | | 0，，01： | 1 |
| 7 | Endoglin:an accessory component of the TGF - beta 1 - binding receptor - complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies显示文摘 | Fonsattie E Del VecchioL Altomonte M | 2001 | J Cell physiol2001，188，： | 1 |
| 8 | Bioimmunotherapentic targets on angiogenetic blood vessels in solid malignangies显示文摘 | Maio M Altomonte M calabro L | 2001 | Front Biosci2001，6，： | 1 |
| 9 | Typical interhemispheric subdural haematomas and falx syndrome: four cases and a review of the literature显示文摘 | Altomonte M Baldini M | 1995 | Zentralbl Neurochir1995，56，2： | 1 |
| 10 | Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-asseciated antigen显示文摘 | Baharav E Mefimsky O Altomonte M | 1995 | Melanoma Res1995，5，： | 1 |
| 11 | Traumatic posterior fossa extradural hematomas显示文摘 | Rivano CM Bortzone M Altomonte T | 1992 | Neurochirurgia1992，35，： | 1 |
| 12 | Expression and structural features of endoglin,a transforming growth factor β1 and β3 binding protein,in human melanoma显示文摘 | Montaagner R Fonsatti F | 1996 | Cancer1996，74，： | 1 |
| 13 | Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels 显示文摘 | Fonsatti E Altomonte M Nieotra M R | 2003 | Oncogene2003，22，42： | 1 |
| 14 | Typical interhemispheric subdural hematomas and falx syndrome;four case and a review of the literature显示文摘 | Borzone M Altomonte M Baldini M | 1995 | Zentralbl Neurochir1995，56，2： | 1 |
| 15 | Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells显示文摘 | Fonsatti E Altomont M Coral S | 1997 | Br J Cancer1997，76，10： | 1 |
| 16 | Engineered new-castle disease virus as an improved oncolytic agent against hepa toeellular carcinoma显示文摘 | Altomonte J Marozin S Schmid R M | 2010 | Mol Ther2010，18，2： | 1 |
| 17 | Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies显示文摘 | Fonsatti E Del Vecchio L Altomonte M | 2001 | J Cell Physiol2001，188，1： | 1 |
| 18 | Typical interhemispheric subduralhaematomas and falx syndrome: four cases and a review of the literature显示文摘 | Borzone M Altomonte M Baldini M | 1995 | ZentralblNeurochir1995，56，2： | 1 |
| 19 | 5-aza-2′-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma:Immunotherapeutic implications显示文摘 | Coral S Sigalotti L Altomonte M | 2002 | Clin Cancer Res2002，8，8： | 1 |
| 20 | Endoglin(CD105):a powerful therapeutictarget on tumor-associated angiogenic blood vessels显示文摘 | FONSATTI E ALTOMONTE M NICOTRA M R | 2003 | Oncogene2003，22，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员